In Conversation: Dr. Vipin K. Garg, CEO of Altimmune

Published on :

Dr. Vipin Garg, Altimmune’s (ALT) CEO since 2018 and a biotech industry veteran, has successfully led the publicly-traded company through these turbulent pandemic waters. We recently caught up with Dr. Garg to discuss the pandemic, Altimmune’s deep product pipeline, his unique perspectives on the BioHealth Capital Region (BHCR), and the state of the U.S. supply chain and biotech manufacturing ecosystem.

What Employers Should Know About Vaccination Requirements, Screenings and Return to Work Plans

Published on :

More than 100 million doses of COVID-19 vaccines have been administered in the United States and many companies are hoping this will signal a significant return to work for most employees. But, before that happens, there may be pending legal questions about vaccination requirements ahead.